1. Home
  2. AMST vs SNGX Comparison

AMST vs SNGX Comparison

Compare AMST & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMST
  • SNGX
  • Stock Information
  • Founded
  • AMST 2017
  • SNGX 1987
  • Country
  • AMST United States
  • SNGX United States
  • Employees
  • AMST N/A
  • SNGX N/A
  • Industry
  • AMST Computer Software: Prepackaged Software
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMST Technology
  • SNGX Health Care
  • Exchange
  • AMST Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • AMST 7.4M
  • SNGX 7.4M
  • IPO Year
  • AMST 2020
  • SNGX 1987
  • Fundamental
  • Price
  • AMST $4.41
  • SNGX $2.94
  • Analyst Decision
  • AMST
  • SNGX
  • Analyst Count
  • AMST 0
  • SNGX 0
  • Target Price
  • AMST N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • AMST 47.6K
  • SNGX 38.8K
  • Earning Date
  • AMST 02-12-2025
  • SNGX 11-08-2024
  • Dividend Yield
  • AMST N/A
  • SNGX N/A
  • EPS Growth
  • AMST N/A
  • SNGX N/A
  • EPS
  • AMST N/A
  • SNGX N/A
  • Revenue
  • AMST $114,798.00
  • SNGX $364,183.00
  • Revenue This Year
  • AMST N/A
  • SNGX N/A
  • Revenue Next Year
  • AMST N/A
  • SNGX $76.64
  • P/E Ratio
  • AMST N/A
  • SNGX N/A
  • Revenue Growth
  • AMST N/A
  • SNGX N/A
  • 52 Week Low
  • AMST $1.85
  • SNGX $1.83
  • 52 Week High
  • AMST $6.27
  • SNGX $15.68
  • Technical
  • Relative Strength Index (RSI)
  • AMST 57.94
  • SNGX 42.46
  • Support Level
  • AMST $4.19
  • SNGX $2.65
  • Resistance Level
  • AMST $5.18
  • SNGX $2.97
  • Average True Range (ATR)
  • AMST 0.53
  • SNGX 0.21
  • MACD
  • AMST -0.01
  • SNGX -0.01
  • Stochastic Oscillator
  • AMST 25.69
  • SNGX 34.94

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: